PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 103 filers reported holding PASSAGE BIO INC in Q4 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $15,242 | +57.1% | 11,290 | +11.5% | 0.00% | – |
| Q1 2023 | $9,701 | -50.1% | 10,129 | -28.1% | 0.00% | – |
| Q4 2022 | $19,437 | -60.3% | 14,085 | -64.1% | 0.00% | – |
| Q3 2022 | $49,000 | -64.0% | 39,210 | -32.0% | 0.00% | -100.0% |
| Q2 2022 | $136,000 | -30.6% | 57,620 | -8.7% | 0.00% | -50.0% |
| Q1 2022 | $196,000 | -37.2% | 63,107 | +28.4% | 0.00% | -33.3% |
| Q4 2021 | $312,000 | +27.9% | 49,130 | +100.5% | 0.00% | 0.0% |
| Q3 2021 | $244,000 | -57.5% | 24,508 | -43.5% | 0.00% | -50.0% |
| Q2 2021 | $574,000 | +205.3% | 43,348 | +302.9% | 0.01% | +200.0% |
| Q1 2021 | $188,000 | – | 10,759 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,959,769 | $49,399,000 | 20.45% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,185,869 | $11,811,000 | 9.97% |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $24,879,000 | 7.18% |
| FRAZIER MANAGEMENT LLC | 5,009,219 | $49,892,000 | 3.99% |
| Orbimed Advisors | 6,962,899 | $69,350,000 | 0.76% |
| Boxer Capital, LLC | 1,928,315 | $19,206,000 | 0.67% |
| Vivo Capital, LLC | 539,263 | $5,371,000 | 0.24% |
| Logos Global Management LP | 125,010 | $1,245,000 | 0.09% |
| Weiss Multi-Strategy Advisers LLC | 336,034 | $3,347,000 | 0.07% |
| Virtus ETF Advisers LLC | 14,687 | $146,000 | 0.06% |